We look for investments that achieve one of our core strategic goals: driving operational efficiency, transforming our current business model, improving access to healthcare, or reimagining the practice of medicine. Investments span every aspect of our business: from research and development, to manufacturing and supply chain, through commercial, medical, and patient care.
Using big data, analytics, ML, AI to improve treatment development, clinical decision support, and disease prevention.
Enterprise software & services that improve research and development, drug discovery, and clinical trial operations.
Enterprise software & services that improve the commercialization of pharma and healthcare products.
Sensors, wearables, software as a medical device, medical iOT, digital therapies and services, and new care delivery models.
Optimizing how our business operates today.
Investing in novel but overlapping products, features, business models.
Fundamentally reimagining technology platforms or business models.
Optimizing how our business operates today
Investing in novel but overlapping products, features, business models
Fundamentally reimagining technology platforms or business models